Search

everythinglearnresearchcommunity

for

Search:↓

Smaller particles of the drug carrier penetrated skin better, with 300 nm size being best for targeting hair follicles.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

Medroxyprogesterone acetate is as effective as oral contraceptives for resuming ovulation in women with PCOS.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

COC treatment improves hormone and metabolic levels in PCOS patients.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Oral contraceptives may cause significant hair loss in women.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

New drug delivery systems improve treatment effectiveness and patient experience.

Newer contraceptives with less androgenic progestins may reduce female hair loss.

Chitosan-coated spironolactone nano carriers effectively treat acne without side effects.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Microneedles offer a painless, effective way to deliver drugs through the skin.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Microemulsions can effectively deliver drugs through the skin but require careful ingredient selection to avoid irritation.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Oral contraceptives may cause hair loss in women.

The combination therapy effectively treats infertility in PCOS without major side effects.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.